Fig. 1 · Structure
Documents & Downloads
Deleobuvir sodium
Cat. No.
A73143
CAS
1370023-80-5
Endogenous Metabolite
Deleobuvir sodium is a non-nucleoside inhibitor of the hepatitis C virus NS5B polymerase, targeting viral replication. This compound exhibits significant anti-hepatitis C virus activity, making it a valuable tool for research into hepatitis C treatment. Its use facilitates the study of viral mechanisms and the development of therapeutic strategies aimed at combating hepatitis C infection.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 1370023-80-5 |
| Applications | Endogenous Metabolite |
| Formula | C34H32BrN6NaO3 |
| Molecular Weight | 675.55 |
| Synonyms | BI 207127 sodium |
| SMILES | CN1C(C2=NC=C(Br)C=N2)=C(C3CCCC3)C4=CC=C(C(NC5(C(N(C6=C7)C)=NC6=CC=C7/C=C/C(O[Na])=O)CCC5)=O)C=C41 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.